NEO

NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management

Retrieved on: 
tisdag, maj 28, 2024

DNA & RNA Lung is a 50-gene NGS panel enriched with MSI and TMB analysis to facilitate precise therapy selection and clinical trial matching.

Key Points: 
  • DNA & RNA Lung is a 50-gene NGS panel enriched with MSI and TMB analysis to facilitate precise therapy selection and clinical trial matching.
  • InvisionFirst® Lung is a liquid biopsy assay that detects 37 genes crucial to NSCLC treatment.
  • NeoGenomics will also feature COMPASS, a suite of single-order sample-to-diagnosis services for hematological malignancies.
  • COMPASS provides an all-in-one assessment with actionable diagnostic and prognostic information unique to the patient.

NEO Semiconductor Reveals a Performance Boosting Floating Body Cell Mechanism for 3D X-DRAM during IEEE IMW 2024 in Seoul, Republic of Korea

Retrieved on: 
måndag, maj 13, 2024

SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- NEO Semiconductor, a leading developer of innovative technologies for 3D NAND flash and DRAM memory, today announced a performance boosting Floating Body Cell Mechanism for 3D X-DRAM. Andy Hsu, Founder & CEO presented groundbreaking Technology CAD (TCAD) simulation results for NEO's 3D X-DRAM™ during the 16th IEEE International Memory Workshop (IMW) 2024 in Seoul, Republic of Korea.

Key Points: 
  • SAN JOSE, Calif., May 13, 2024 /PRNewswire/ -- NEO Semiconductor , a leading developer of innovative technologies for 3D NAND flash and DRAM memory, today announced a performance boosting Floating Body Cell Mechanism for 3D X-DRAM.
  • Neo Semiconductor reveals a unique performance boosting mechanism called Back-gate Channel-depth Modulation (BCM) for Floating Body Cell that can increase data retention by 40,000X and sensing window by 20X.
  • "Unlike the traditional 2D Floating Body Cell that uses body effect to change the cell current, our BCM mechanism employs a back-gate voltage to modulate the channel depth.
  • NEO Semiconductor's 3D X-DRAM™ is a first-of-its-kind 3D NAND-like DRAM cell array structure based on floating body cell technology.

DeFi Technologies Provides Monthly Corporate Update: Subsidiary Valour Reports Assets Under Management at C$748 Million, Up 47.2% This Fiscal Year, Bolstered by Strong Net Inflows of C$6.6 Million, Among Other Key Developments

Retrieved on: 
onsdag, maj 8, 2024

Significant Growth in Assets Under Management: Valour Inc., a subsidiary of DeFi Technologies, reports assets under management of C$748 million as of May 7, 2024, marking a notable year-on-year increase of 47.2%.

Key Points: 
  • Significant Growth in Assets Under Management: Valour Inc., a subsidiary of DeFi Technologies, reports assets under management of C$748 million as of May 7, 2024, marking a notable year-on-year increase of 47.2%.
  • This expansion is aimed at making ETPs globally accessible and tapping into the Middle East's dynamic financial landscape.
  • Additionally, Valour has launched the first Short Spot Bitcoin ETP in the Nordics, known as Valour Short Bitcoin (SBTC) SEK, independently from the Core collaboration.
  • We are excited about our future prospects and remain dedicated to advancing our position in the digital asset space."

Payroc and ID TECH Join Forces to Launch the NEO 3 Platform of Products, Enhancing Unattended Payment Solutions

Retrieved on: 
tisdag, maj 7, 2024

TINLEY PARK, Ill., May 7, 2024 /PRNewswire-PRWeb/ -- Payroc, a leading provider of integrated payment processing solutions, is thrilled to announce its collaboration with ID TECH, a pioneer in payment device technology, to unveil the cutting-edge ID TECH NEO 3 Platform of Products. Engineered specifically for independent software vendors (ISVs) operating in unattended and self-service environments, the NEO 3 line integrates seamlessly with the Payroc gateway, representing a significant milestone in the evolution of integrated payment solutions.

Key Points: 
  • Payroc and ID TECH partner to launch the NEO 3 line of products, starting with the VP3350, a compact card reader perfect for unattended and mobile payment environments
    TINLEY PARK, Ill., May 7, 2024 /PRNewswire-PRWeb/ -- Payroc, a leading provider of integrated payment processing solutions, is thrilled to announce its collaboration with ID TECH, a pioneer in payment device technology, to unveil the cutting-edge ID TECH NEO 3 Platform of Products.
  • "Payroc has been a valuable and trusted partner of ID TECH for more than a decade, and we are excited to combine our expertise in unattended hardware with Payroc's powerful platform to provide ISVs with premier unattended payment solutions," said Bill Rorick, Chief Revenue Officer of ID TECH.
  • The cornerstone of the NEO 3 Platform of Products is the VP3350, a successor to the VP3300, and is now empowered by the robust capabilities of the Payroc payment gateway.
  • For more information about the ID TECH NEO 3 Platform of Products and Payroc's integrated payment solutions, please visit http://www.idtechproducts.com and http://www.payroc.com .

Short Shorts Film Festival & Asia (SSFF & ASIA) Announces Special Program & Program Selection at Nippon Connection in Frankfurt, Germany

Retrieved on: 
måndag, maj 6, 2024

SHIBUYA WARD, Japan, May 6, 2024 /PRNewswire/ -- Short Shorts Film Festival & Asia (SSFF & ASIA) proudly announces the collaboration screening with the film festival "Nippon Connection" in Frankfurt, Germany will be held on May 30, May 31, and June 2.

Key Points: 
  • Screening Japan's 6 short films including Grand-Prix and Japan Category Best Short Award winners on May 30, May 31, and June 2
    SHIBUYA WARD, Japan, May 6, 2024 /PRNewswire/ -- Short Shorts Film Festival & Asia (SSFF & ASIA) proudly announces the collaboration screening with the film festival "Nippon Connection" in Frankfurt, Germany will be held on May 30, May 31, and June 2.
  • Florian Höhr, a programmer of Nippon Connection commented, "We at Nippon Connection are proud to be working with the renowned SSFF & ASIA to present six films from the festival's strong and diverse line-up.
  • Also, "Short Shorts Film Festival Asia (SSFF ASIA)" was born with the aim of disseminating new visual culture from Asia and nurturing up-and-coming young filmmakers.
  • We are holding a film festival under the collective name "SSFF & ASIA".

Growatt Introduces NEO 800M-X Microinverter and NOAH 2000 Battery Balcony Solar Solution

Retrieved on: 
torsdag, maj 2, 2024

BERLIN, May 2, 2024 /PRNewswire/ -- Growatt, a global leader in energy solutions across residential, commercial, industrial, and energy storage sectors, has announced its latest offerings: the NEO 800M-X microinverter and NOAH 2000 Battery Balcony Solar Solution.

Key Points: 
  • BERLIN, May 2, 2024 /PRNewswire/ -- Growatt, a global leader in energy solutions across residential, commercial, industrial, and energy storage sectors, has announced its latest offerings: the NEO 800M-X microinverter and NOAH 2000 Battery Balcony Solar Solution.
  • Frank Qiao, Sales Director at Growatt, emphasized that this solution directly addresses the needs of modern apartment living, providing a comprehensive solar energy solution backed by a 10-year warranty.
  • The NOAH 2000 Battery complements balcony solar setups by enabling efficient energy storage, allowing owners to store and utilize electricity generated by their balcony solar systems at their convenience.
  • The NEO and NOAH balcony solar energy storage solution is a further step that marks the company's commitment to enabling sustainable energy for all, empowering families to harness solar power effectively and enjoy the advantages of energy storage.

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

Retrieved on: 
tisdag, april 30, 2024

VANCOUVER, BC, April 30, 2024 /PRNewswire/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is being witnessed in Canada, the USA, and the EU, with extra concern to patients thought to be in remission contracting breast cancer a second time, according to a new study from the University of Cambridge. However, there's still optimism towards new treatments, and significant growth of 9.3% CAGR in the metastatic HR+/HER2- breast cancer market through 2032 has treatment developers working harder to make gains for patients. Among the biotech companies currently making strides are Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), IceCure Medical Ltd (NASDAQ: ICCM), Atossa Therapeutics, Inc. (NASDAQ: ATOS), Arvinas, Inc. (NASDAQ: ARVN), and Pfizer Inc. (NYSE: PFE) (NEO: PFE).

Key Points: 
  • Recently, Oncolytics announced that they had submitted a Type C meeting request to the FDA to discuss a forthcoming trial for pelareorep aimed at treating HR+/HER2- metastatic breast cancer (mBC) patients.
  • "A key focus for Oncolytics in 2024 is defining the regulatory path for pelareorep in breast cancer treatment," said Matt Coffey, President and CEO of Oncolytics.
  • "We are optimistic that pelareorep, in combination with paclitaxel, could significantly enhance clinical outcomes for patients with HR+/HER2- metastatic breast cancer.
  • The company looks forward to meeting with the FDA in Q2 2024 to finalize the trial design and goals for using pelareorep in treating metastatic breast cancer.

As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

Retrieved on: 
tisdag, april 30, 2024

VANCOUVER, BC, April 30, 2024 /PRNewswire/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is being witnessed in Canada, the USA, and the EU, with extra concern to patients thought to be in remission contracting breast cancer a second time, according to a new study from the University of Cambridge. However, there's still optimism towards new treatments, and significant growth of 9.3% CAGR in the metastatic HR+/HER2- breast cancer market through 2032 has treatment developers working harder to make gains for patients. Among the biotech companies currently making strides are Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), IceCure Medical Ltd (NASDAQ: ICCM), Atossa Therapeutics, Inc. (NASDAQ: ATOS), Arvinas, Inc. (NASDAQ: ARVN), and Pfizer Inc. (NYSE: PFE) (NEO: PFE).

Key Points: 
  • Recently, Oncolytics announced that they had submitted a Type C meeting request to the FDA to discuss a forthcoming trial for pelareorep aimed at treating HR+/HER2- metastatic breast cancer (mBC) patients.
  • "A key focus for Oncolytics in 2024 is defining the regulatory path for pelareorep in breast cancer treatment," said Matt Coffey, President and CEO of Oncolytics.
  • "We are optimistic that pelareorep, in combination with paclitaxel, could significantly enhance clinical outcomes for patients with HR+/HER2- metastatic breast cancer.
  • The company looks forward to meeting with the FDA in Q2 2024 to finalize the trial design and goals for using pelareorep in treating metastatic breast cancer.

Generative AI Surge Triggers Nationwide Rush for New Data Center Infrastructure

Retrieved on: 
måndag, april 29, 2024

VANCOUVER, British Columbia, April 29, 2024 /PRNewswire/ -- USA News Group News Commentary – Demand for new AI Data Centers which are powering the rise of such popular AI platforms as OpenAI's ChatGPT is being grossly underestimated according to analysts at this year's Bloomberg Intelligence summit. The ongoing generative AI boom is kicking off a rush for new data centers, and the providers of the infrastructure behind them. With this boom comes many challenges including power supplies and the price of necessary hardware. For 9 of the top 10 US electric utilities, data centers have been the main source of customer growth, according to analysis made by Reuters. The booming Global Data Center Market is expected to hit US$792.3 billion by 2032, according to Astute Analytica, while analysts at Christian & Timbers have identified what they believe will be a 27% increase in AI data center talent demand in 2024 over 2023. Behind the scenes are several developers advancing the data center surge, who over the last week updated the market with recent developments, including: Avant Technologies Inc. (OTC: AVAI), Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) (NEO: GOOG), Meta Platforms, Inc. (NASDAQ: META) (NEO: META), Pegasystems Inc. (NASDAQ: PEGA), and Advanced Micro Devices, Inc. (NASDAQ: AMD).

Key Points: 
  • The ongoing generative AI boom is kicking off a rush for new data centers , and the providers of the infrastructure behind them.
  • Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers
    Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today its plans to implement a Zero Trust Architecture (ZTA) framework powered by AI within its data center operations.
  • "This combined approach ensures the highest level of security for our customers' data while optimizing data center operations for efficiency and cost-effectiveness.
  • Such advantages are vital for businesses aiming to upgrade their data center infrastructure and enhance computational capacity while actively striving to meet sustainability objectives.

Generative AI Surge Triggers Nationwide Rush for New Data Center Infrastructure

Retrieved on: 
måndag, april 29, 2024

VANCOUVER, British Columbia, April 29, 2024 /PRNewswire/ -- USA News Group News Commentary – Demand for new AI Data Centers which are powering the rise of such popular AI platforms as OpenAI's ChatGPT is being grossly underestimated according to analysts at this year's Bloomberg Intelligence summit. The ongoing generative AI boom is kicking off a rush for new data centers, and the providers of the infrastructure behind them. With this boom comes many challenges including power supplies and the price of necessary hardware. For 9 of the top 10 US electric utilities, data centers have been the main source of customer growth, according to analysis made by Reuters. The booming Global Data Center Market is expected to hit US$792.3 billion by 2032, according to Astute Analytica, while analysts at Christian & Timbers have identified what they believe will be a 27% increase in AI data center talent demand in 2024 over 2023. Behind the scenes are several developers advancing the data center surge, who over the last week updated the market with recent developments, including: Avant Technologies Inc. (OTC: AVAI), Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL) (NEO: GOOG), Meta Platforms, Inc. (NASDAQ: META) (NEO: META), Pegasystems Inc. (NASDAQ: PEGA), and Advanced Micro Devices, Inc. (NASDAQ: AMD).

Key Points: 
  • The ongoing generative AI boom is kicking off a rush for new data centers , and the providers of the infrastructure behind them.
  • Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers
    Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an artificial intelligence technology (AI) company specializing in the development of advanced AI and data center infrastructure solutions, announced today its plans to implement a Zero Trust Architecture (ZTA) framework powered by AI within its data center operations.
  • "This combined approach ensures the highest level of security for our customers' data while optimizing data center operations for efficiency and cost-effectiveness.
  • Such advantages are vital for businesses aiming to upgrade their data center infrastructure and enhance computational capacity while actively striving to meet sustainability objectives.